Loading fund overlap…
17 of 123 unique stocks in common · Jaccard: 13.8%
A weighted portfolio overlap of 28.46% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹28.46 is allocated to the exact same companies at the same relative proportions. The schemes share 17 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 7.09% in ICICI Prudential ELSS Tax Saver Fund and 8.22% in Tata Large & Mid Cap Fund. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in ICICI | in Tata |
|---|---|---|
| HDFC BankBanks | 7.09% | 8.22% |
| Reliance IndustriesPetroleum Products | 5.49% | 3.90% |
| ICICI BankBanks | 7.43% | 3.71% |
| Bharti AirtelTelecom - Services | 2.51% | 3.94% |
| Larsen & ToubroConstruction | 4.90% | 1.90% |
| State Bank of IndiaBanks | 1.48% | 5.20% |
| SBI Cards and Payment ServicesFinance | 1.29% | 3.69% |
| PI IndustriesFertilizers & Agrochemicals | 1.16% | 3.77% |
| Tata Consultancy ServicesIT - Software | 1.09% | 0.91% |
| Ultratech CementCement & Cement Products | 1.93% | 0.83% |
| Ambuja CementsCement & Cement Products | 0.83% | 1.44% |
| WockhardtPharmaceuticals & Biotechnology | 0.74% | 2.55% |
| InfosysIT - Software | 1.85% | 0.68% |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | 0.60% | 0.44% |
| ITCDiversified FMCG | 0.37% | 0.85% |
| Tega IndustriesIndustrial Manufacturing | 0.32% | 2.72% |
| Sundram FastenersAuto Components | 0.32% | 1.61% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.